Presented by Jeffrey Ponskey, MD at the SAGES 2014 Meeting; Symposium: Ethics of Innovation
issues to consider–24 sec
utility–1:11
facilitating technologies–2:15
disruptive technologies–5:40
evaluating efficacy–9:27
evaluating competing use of funds–10:42
not all new technology i
Keyword(s): administrators, Angelchick prosthesis, Barretts esophagus, BaRRX, blood vessel ligation, capital budget, cautery, CBD injury, competing funds, cost, CT, death, Dornier lithotripter, downstream revenue, dysplastic varices, EEA stapler, efficacy, EGJ, emerging technologies, endoluminal surgery, endovascular surgery, ENT, esophageal varices, esophagectomy, ethics, extracorporeal lithotripsy, frequency of use, gastric bubble, GERD, Harmonic Scalpel, hemorrhoidal banding, hemostat, injury, innovation, internal rate of return, intestinal anastomosis, investment, IRB approved trial, lap prostatectomy, laser, LC, marketing value, mechanical stapler, MRI, net present value, Nissen fundoplication, NOSCAR, NOTES, operating budget, payback period, porta caval shunt, pt safety, radiofrequency energy, radiosurgery, rectal anastomosis, residents, return on investment, robotic LC, short gastrics, SILS, society, standard, staple remover, surgical robot, TAVR, TIF, urinary stones, urologic operation, utility, vacuum dressing, videoscopic surgery, wet to dry dressing, wound closure